{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:47:06Z","timestamp":1740138426818,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Generation Trust"},{"name":"Friend of Guy\u2019s Hospital Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12022-016-9451-6","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T22:06:08Z","timestamp":1475618768000},"page":"41-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A"],"prefix":"10.1007","volume":"28","author":[{"given":"William","family":"Grey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaline","family":"Hulse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Yakovleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilyana","family":"Genkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Whitelaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador J.","family":"Diaz-Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1258-4843","authenticated-orcid":false,"given":"Louise","family":"Izatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,5]]},"reference":[{"key":"9451_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","volume":"42","author":"M Takahashi","year":"1985","unstructured":"Takahashi M, Ritz J, Cooper GM (1985) Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42:581\u2013588. doi: 10.1016\/0092-8674(85)90115-1","journal-title":"Cell"},{"key":"9451_CR2","doi-asserted-by":"crossref","unstructured":"Takahashi M, Cooper GM (1987) ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7:1378\u20131385.","DOI":"10.1128\/MCB.7.4.1378"},{"key":"9451_CR3","first-page":"571","volume":"3","author":"M Takahashi","year":"1988","unstructured":"Takahashi M, Buma Y, Iwamoto T, et al. (1988) Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3:571\u2013578.","journal-title":"Oncogene"},{"key":"9451_CR4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0168-9525(01)02420-9","volume":"17","author":"S Mani\u00e9","year":"2001","unstructured":"Mani\u00e9 S, Santoro M, Fusco A, Billaud M (2001) The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet 17:580\u20139.","journal-title":"Trends Genet"},{"key":"9451_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0092-8674(00)81311-2","volume":"85","author":"S Jing","year":"1996","unstructured":"Jing S, Wen D, Yu Y, et al. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113\u20131124. doi: 10.1016\/S0092-8674(00)81311-2","journal-title":"Cell"},{"key":"9451_CR6","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1038\/sj.onc.1209669","volume":"25","author":"N Mise","year":"2006","unstructured":"Mise N, Drosten M, Racek T, et al. (2006) Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. Oncogene 25:6637\u201347. doi: 10.1038\/sj.onc.1209669","journal-title":"Oncogene"},{"key":"9451_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00268-006-0769-y","volume":"31","author":"A Machens","year":"2007","unstructured":"Machens A, Dralle H (2007) Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg 31:957\u2013968. doi: 10.1007\/s00268-006-0769-y","journal-title":"World J Surg"},{"key":"9451_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D, et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851\u2013856. doi: 10.1093\/hmg\/2.7.851","journal-title":"Hum Mol Genet"},{"key":"9451_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS, et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458\u2013460. doi: 10.1038\/363458a0","journal-title":"Nature"},{"key":"9451_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1136\/jmg.32.12.934","volume":"32","author":"C Eng","year":"1995","unstructured":"Eng C, Crossey PA, Mulligan LM, et al. (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J Med Genet 32:934\u2013937. doi: 10.1136\/jmg.32.12.934","journal-title":"J Med Genet"},{"key":"9451_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/367375a0","volume":"367","author":"RM Hofstra","year":"1994","unstructured":"Hofstra RM, Landsvater RM, Ceccherini I, et al. (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375\u2013376. doi: 10.1038\/367375a0","journal-title":"Nature"},{"key":"9451_CR12","doi-asserted-by":"publisher","first-page":"a009233","DOI":"10.1101\/cshperspect.a009233","volume":"5","author":"M Santoro","year":"2013","unstructured":"Santoro M, Carlomagno F (2013) Central role of RET in thyroid cancer. Cold Spring Harb Perspect Biol 5:a009233. doi: 10.1101\/cshperspect.a009233","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9451_CR13","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.cellsig.2014.03.032","volume":"26","author":"I Plaza-Menacho","year":"2014","unstructured":"Plaza-Menacho I, Mologni L, McDonald NQ (2014) Mechanisms of RET signaling in cancer: current and future implications for targeted therapy. Cell Signal 26:1743\u201352. doi: 10.1016\/j.cellsig.2014.03.032","journal-title":"Cell Signal"},{"key":"9451_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PLM Dahia","year":"2014","unstructured":"Dahia PLM (2014) Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14:108\u201319. doi: 10.1038\/nrc3648","journal-title":"Nat Rev Cancer"},{"key":"9451_CR15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/jnci\/djh226","volume":"96","author":"M Drosten","year":"2004","unstructured":"Drosten M, Hilken G, Bockmann M, et al. (2004) Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma. J Natl Cancer Inst 96:1231\u20131239. doi: 10.1093\/jnci\/djh226","journal-title":"J Natl Cancer Inst"},{"key":"9451_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"Cooper DS, Doherty GM, Haugen BR, et al. (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167\u20131214. doi: 10.1089\/thy.2009.0110","journal-title":"Thyroid"},{"key":"9451_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Eng C, Evans DB, et al. (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565\u2013612. doi: 10.1089\/thy.2008.0403","journal-title":"Thyroid"},{"key":"9451_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jpedsurg.2007.09.043","volume":"43","author":"EA Fialkowski","year":"2008","unstructured":"Fialkowski EA, DeBenedetti MK, Moley JF, Bachrach B (2008) RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds. J Pediatr Surg 43:188\u2013190. doi: 10.1016\/j.jpedsurg.2007.09.043","journal-title":"J Pediatr Surg"},{"key":"9451_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells","year":"2015","unstructured":"Wells SA, Asa SL, Dralle H, et al. (2015) Revised american thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567\u2013610. doi: 10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"key":"9451_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1385-299X(03)00023-0","volume":"11","author":"M Tanaka","year":"2003","unstructured":"Tanaka M, Xiao H, Hirata Y, Kiuchi K (2003) A rapid assay for glial cell line-derived neurotrophic factor and neurturin based on transfection of cells with tyrosine hydroxylase promoter-luciferase construct. Brain Res Brain Res Protoc 11:119\u201322.","journal-title":"Brain Res Brain Res Protoc"},{"key":"9451_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1006\/bbrc.2001.4338","volume":"281","author":"Y Hayashi","year":"2001","unstructured":"Hayashi Y, Iwashita T, Murakamai H, et al. (2001) Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation. Biochem Biophys Res Commun 281:682\u20139. doi: 10.1006\/bbrc.2001.4338","journal-title":"Biochem Biophys Res Commun"},{"key":"9451_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1210\/me.2003-0173","volume":"18","author":"E Arighi","year":"2004","unstructured":"Arighi E, Popsueva A, Degl\u2019Innocenti D, et al. (2004) Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung\u2019s disease. Mol Endocrinol 18:1004\u201317. doi: 10.1210\/me.2003-0173","journal-title":"Mol Endocrinol"},{"key":"9451_CR23","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1074\/jbc.M608952200","volume":"282","author":"I Plaza-Menacho","year":"2007","unstructured":"Plaza-Menacho I, Van Der Sluis T, Hollema H, et al. (2007) Ras\/ERK1\/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation. J Biol Chem 282:6415\u20136424. doi: 10.1074\/jbc.M608952200","journal-title":"J Biol Chem"},{"key":"9451_CR24","unstructured":"Menacho IP, Koster R, Sloot AM Van Der, et al. (2005) RET-Familial Medullary Thyroid Carcinoma Mutants Y791F and S891A Activate a Src\/JAK\/STAT3 Pathway, Independent of Glial Cell Line \u2212 Derived Neurotrophic Factor of Glial Cell Line \u2013 Derived Neurotrophic Factor. 1729\u20131737."},{"key":"9451_CR25","doi-asserted-by":"publisher","unstructured":"Xing S (1998) Signal Transduction Pathways Activated by RET Oncoproteins in PC12 Pheochromocytoma Cells. J Biol Chem 273:4909\u20134914. doi: 10.1074\/jbc.273.9.4909","DOI":"10.1074\/jbc.273.9.4909"},{"key":"9451_CR26","unstructured":"Tacito A, Vivaldi A, Ciampi R, et al. (2013) Genetic Screening Of RET Can Identify New Mutations Even After 20 Years. Thyroid World Congr."},{"key":"9451_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1056\/NEJM197308302890901","volume":"289","author":"HJ Wolfe","year":"1973","unstructured":"Wolfe HJ, Melvin KE, Cervi-Skinner SJ, et al. (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289:437\u201341. doi: 10.1056\/NEJM197308302890901","journal-title":"N Engl J Med"},{"key":"9451_CR28","first-page":"237","volume":"36","author":"RA DeLellis","year":"1977","unstructured":"DeLellis RA, Nunnemacher G, Wolfe HJ (1977) C-cell hyperplasia. An ultrastructural analysis. Lab Invest 36:237\u201348.","journal-title":"Lab Invest"},{"key":"9451_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1101\/gr.3577405","volume":"15","author":"GM Cooper","year":"2005","unstructured":"Cooper GM, Stone EA, Asimenos G, et al. (2005) Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 15:901\u2013913. doi: 10.1101\/gr.3577405","journal-title":"Genome Res"},{"key":"9451_CR30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/hmg\/5.10.1577","volume":"5","author":"T Iwashita","year":"1996","unstructured":"Iwashita T, Murakami H, Asai N, Takahashi M (1996) Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum Mol Genet 5:1577\u201380.","journal-title":"Hum Mol Genet"},{"key":"9451_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/humu.22170","volume":"34","author":"BD Hyndman","year":"2013","unstructured":"Hyndman BD, Gujral TS, Krieger JR, et al. (2013) Multiple functional effects of RET kinase domain sequence variants in Hirschsprung disease. Hum Mutat 34:132\u201342. doi: 10.1002\/humu.22170","journal-title":"Hum Mutat"},{"key":"9451_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-014-3538-2","author":"D Coyle","year":"2014","unstructured":"Coyle D, Friedmacher F, Puri P (2014) The association between Hirschsprung\u2019s disease and multiple endocrine neoplasia type 2a: a systematic review. Pediatr Surg Int. doi: 10.1007\/s00383-014-3538-2","journal-title":"Pediatr Surg Int"},{"key":"9451_CR33","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/humu.20896","volume":"29","author":"SV Tavtigian","year":"2008","unstructured":"Tavtigian S V., Byrnes GB, Goldgar DE, Thomas A (2008) Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications. Hum Mutat 29:1342\u20131354. doi: 10.1002\/humu.20896","journal-title":"Hum Mutat"},{"key":"9451_CR34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/ERC-11-0117","volume":"18","author":"B Cosci","year":"2011","unstructured":"Cosci B, Vivaldi A, Romei C, et al. (2011) In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer. Endocr Relat Cancer 18:603\u201312. doi: 10.1530\/ERC-11-0117","journal-title":"Endocr Relat Cancer"},{"key":"9451_CR35","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.1210\/en.2004-0922","volume":"145","author":"M Santoro","year":"2004","unstructured":"Santoro M, Melillo RM, Carlomagno F, et al. (2004) Minireview: RET: normal and abnormal functions. Endocrinology 145:5448\u201351. doi: 10.1210\/en.2004-0922","journal-title":"Endocrinology"},{"key":"9451_CR36","doi-asserted-by":"publisher","unstructured":"Kambouris M, Jackson CE, Feldman GL (1996) Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations. Hum Mutat 8:64\u201370. doi: 10.1002\/(SICI)1098-1004(1996)8:1<64::AID-HUMU9>3.0.CO;2-P","DOI":"10.1002\/(SICI)1098-1004(1996)8:1<64::AID-HUMU9>3.0.CO;2-P"},{"key":"9451_CR37","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1172\/JCI375","volume":"101","author":"A Pelet","year":"1998","unstructured":"Pelet A, Geneste O, Edery P, et al. (1998) Various mechanisms cause RET-mediated signaling defects in Hirschsprung\u2019s disease. J Clin Invest 101:1415\u20131423. doi: 10.1172\/JCI375","journal-title":"J Clin Invest"},{"key":"9451_CR38","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009134","author":"CF Ib\u00e1\u00f1ez","year":"2013","unstructured":"Ib\u00e1\u00f1ez CF (2013) Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb Perspect Biol. doi: 10.1101\/cshperspect.a009134","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9451_CR39","doi-asserted-by":"publisher","unstructured":"Viola D ME, E M, L A, et al. (2014) Ret Oncogene and Thyroid Carcinoma. J Genet Syndr Gene Ther. doi: 10.4172\/2157-7412.1000214","DOI":"10.4172\/2157-7412.1000214"},{"key":"9451_CR40","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1210\/jc.86.8.3948","volume":"86","author":"SJ Diaz-Cano","year":"2001","unstructured":"Diaz-Cano SJ, De Miguel M, Blanes A, et al. (2001) Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia. J Clin Endocrinol Metab 86:3948\u20133957. doi: 10.1210\/jc.86.8.3948","journal-title":"J Clin Endocrinol Metab"},{"key":"9451_CR41","unstructured":"Ponder BA (1999) The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome. Cancer Res 59:1736s\u20131741s; discussion 1742s."},{"key":"9451_CR42","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/emboj\/19.4.612","volume":"19","author":"CL Smith-Hicks","year":"2000","unstructured":"Smith-Hicks CL, Sizer KC, Powers JF, et al. (2000) C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J 19:612\u201322. doi: 10.1093\/emboj\/19.4.612","journal-title":"EMBO J"},{"key":"9451_CR43","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1210\/jc.2004-0365","volume":"89","author":"G Orgiana","year":"2004","unstructured":"Orgiana G, Pinna G, Camedda A, et al. (2004) A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure. J Clin Endocrinol Metab 89:4810\u20136. doi: 10.1210\/jc.2004-0365","journal-title":"J Clin Endocrinol Metab"},{"key":"9451_CR44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000478-200302000-00018","volume":"27","author":"L Mears","year":"2003","unstructured":"Mears L, Diaz-Cano SJ (2003) Difference between familial and sporadic medullary thyroid carcinomas. Am J Surg Pathol 27:266\u20137.","journal-title":"Am J Surg Pathol"},{"key":"9451_CR45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.1987.tb00845.x","volume":"27","author":"ED Williams","year":"1987","unstructured":"Williams ED, Ponder BJ, Craig RK (1987) Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia. Clin Endocrinol (Oxf) 27:107\u2013114.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-016-9451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-016-9451-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-016-9451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:22:37Z","timestamp":1498335757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-016-9451-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9451"],"URL":"https:\/\/doi.org\/10.1007\/s12022-016-9451-6","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"type":"print","value":"1046-3976"},{"type":"electronic","value":"1559-0097"}],"subject":[],"published":{"date-parts":[[2016,10,5]]}}}